Biomarkers Market By Biomarker Type (Safety, Efficacy, and Validation), By Application (Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), and By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

  • TBI589345
  • July 24, 2020
  • Global
  • 132 pages
  • SAC Insights


The report covers a forecast and an analysis of the biomarkers market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the biomarkers market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the biomarkers market on a global level. In order to give the users a comprehensive view of the biomarkers market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness. The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis. The study provides a decisive view of the biomarkers market by segmenting it based on biomarker type, application, disease, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Some key players in the global biomarkers market are Agilent Technologies, F. Hoffmann-La Roche, Epigenomics, Abbott, Thermo Fisher Scientific, Johnson & Johnson, Siemens Healthcare, Bio-Rad Laboratories, and Qiagen. This report segments the global biomarkers market into: Global Biomarkers Market: Biomarker Type Analysis Safety Biomarkers Efficacy Biomarkers Validation Biomarkers Global Biomarkers Market: Application Analysis Diagnostic Drug Discovery and Development Personalized Medicine Others Global Biomarkers Market: Technology Analysis Cancer Cardiovascular Diseases Neurological Diseases Immunological Diseases Others Global Biomarkers Market: Regional Analysis North America The U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

Table of Contents
                         Request Table Of Content
                         Click To Request Sample

	Chapter 1. Introduction
		1.1. Report description and scope
		1.2. Research scope
		1.3. Research methodology
			1.3.1. Market research process
			1.3.2. Market research methodology
	Chapter 2. Executive Summary
		2.1. Global Biomarkers Market, 2016-2025 (USD Billion)
		2.2. Global Biomarkers Market: Snapshot
	Chapter 3. Biomarkers Market 
| 

Request a sample

Fill below form to request a sample


Please fill this form to enquire before buying


You can request for discount regarding the report by using below form